FR2348207B1 - - Google Patents

Info

Publication number
FR2348207B1
FR2348207B1 FR7711801A FR7711801A FR2348207B1 FR 2348207 B1 FR2348207 B1 FR 2348207B1 FR 7711801 A FR7711801 A FR 7711801A FR 7711801 A FR7711801 A FR 7711801A FR 2348207 B1 FR2348207 B1 FR 2348207B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7711801A
Other languages
French (fr)
Other versions
FR2348207A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Investigacion Tecnica y Aplicada SA
Original Assignee
Investigacion Tecnica y Aplicada SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Investigacion Tecnica y Aplicada SA filed Critical Investigacion Tecnica y Aplicada SA
Publication of FR2348207A1 publication Critical patent/FR2348207A1/fr
Application granted granted Critical
Publication of FR2348207B1 publication Critical patent/FR2348207B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
FR7711801A 1976-04-15 1977-04-14 Derive a liaison peptidique utilisable en medecine humaine et son procede de preparation Granted FR2348207A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES447114A ES447114A1 (es) 1976-04-15 1976-04-15 Nuevo procedimiento para la preparacion de derivados con en-lace peptidico.

Publications (2)

Publication Number Publication Date
FR2348207A1 FR2348207A1 (fr) 1977-11-10
FR2348207B1 true FR2348207B1 (enExample) 1980-02-08

Family

ID=8471384

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7711801A Granted FR2348207A1 (fr) 1976-04-15 1977-04-14 Derive a liaison peptidique utilisable en medecine humaine et son procede de preparation

Country Status (5)

Country Link
JP (1) JPS52128383A (enExample)
DE (1) DE2716374C2 (enExample)
ES (1) ES447114A1 (enExample)
FR (1) FR2348207A1 (enExample)
GB (1) GB1535683A (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES472295A1 (es) * 1978-08-02 1979-02-16 Invest Tecnica Aplicada Procedimiento de obtencion de nuevas acilureas con actividadfarmacologica
CA2052014A1 (en) * 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1296513B (de) * 1965-12-30 1969-05-29 Adox Du Pont Fotowerke Verfahren zum Haerten von gelatinehaltigen photographischen Schichten, insbesondere Halogensilberemulsionsschichten
US3927092A (en) * 1968-06-24 1975-12-16 Merck & Co Inc Amides of 2-{8 halophenoxy (or halophenylthio){9 -alkanoic acids
DE1936282A1 (de) * 1969-07-17 1971-01-28 Ruhrchemie Ag Verfahren zur Herstellung von N,N'-disubstituierten Harnstoffen und Thioharnstoffen
FR2187311B1 (enExample) * 1972-06-02 1975-06-20 Bouchara Emile

Also Published As

Publication number Publication date
DE2716374C2 (de) 1986-09-25
FR2348207A1 (fr) 1977-11-10
GB1535683A (en) 1978-12-13
DE2716374A1 (de) 1977-11-03
ES447114A1 (es) 1977-11-01
JPS52128383A (en) 1977-10-27

Similar Documents

Publication Publication Date Title
CS177772B1 (enExample)
CS190780B1 (enExample)
DD125294A1 (enExample)
DD125283A1 (enExample)
BG23177A1 (enExample)
BG23185A1 (enExample)
BG23391A1 (enExample)
CH591224A5 (enExample)
CH594948A5 (enExample)
CH595682A5 (enExample)
CH595987A5 (enExample)
CH596002A5 (enExample)
CH596052A5 (enExample)
CH596689A5 (enExample)
CH596798A5 (enExample)
CH596895A5 (enExample)
CH598633B5 (enExample)
CH600259A5 (enExample)
CH601880A5 (enExample)
DD125432A1 (enExample)
CH603891B5 (enExample)
CH605286A5 (enExample)
CH606491A5 (enExample)
CH606629A5 (enExample)
CH606663A5 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse